Clinical Trial

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Complex

Study acronym: COSINE
Recruiting
View on ClinicalTrials.gov →
Summary
Multicenter, multinational Post-Market Clinical Follow-Up (PMCF) study on the safety and performance of Ennovate® Complex - A prospective, pure data collection of all Ennovate® scoliosis patients in selected centers (not interventional, multicentric)
Protocol Amendment History 1 change
notable Primary completion pushed: 2026-04 -> 2026-12 2026-06-03
Trial Details
NCT Number NCT05281757
Lead Sponsor Aesculap AG
Collaborators: Raylytic GmbH
Conditions Hyperkyphosis, Hyperlordosis, Congenital Scoliosis, Neuromuscular Scoliosis, Idiopathic Scoliosis
Enrollment 200 participants
Start Date 2022-02-18
Primary Completion 2026-12 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2026-06-02